MSD closed 2023 with a turnover of 55.5 billion euros, 1% more than in 2022, when it obtained sales of 54.7 billion euros. The pharmaceutical company...
PharmaMar's profits rebound with a 64% increase to 2.3 million euros in Q1 2024 compared to the same period last year. Total revenues dropped by 19.45%...
Grifols reports positive results from its Phase IV study of Fanhdi for von Willebrand disease (VWD) treatment, showing safety and efficacy. Presented at the 2024 World...
Vithas and MSD have formed an alliance to enhance patient care, especially in cancer treatment. The collaboration focuses on innovation, research, and education, coinciding with the...
In 2022, spending on biotechnology Research and Development (R&D) increased by 13% to reach 2.56 billion euros. Company expenditure grew by 17.8%, accounting for 47.7% of...
The AI boom extends to mental health, with startups emerging in Spain aiming to leverage technology for patient and professional benefits. Solutions like MoodCapture detect mental...
The metaverse's application to healthcare is projected to surge from $9.5 billion in 2023 to $79.6 billion by 2028, with an annual growth rate of 52%....
Vytrus Biotech's first-quarter 2024 sales surged by 32% compared to 2023, driven by skin and hair care products. The US and European markets led the growth,...
Vertex announced plans to acquire Alpine Immune Sciences for $4.9 billion, primarily for its experimental drug povetacicept to treat IgA nephropathy. Vertex will pay $65 per...
Reig Jofre invests €5.8 million in Leanbio for vertical integration in biotechnology. They increase their stake to 24%, committing to expanding further. The collaboration aims to...